This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)
Vital Pursuits Cauliflower Crust Three Meat Pizza has 400 calories and 32% of the recommended daily value of protein, for example, but it also contains 40% of the recommended sodium and saturated fat
Leah Joseph, MD, FACP , youll receive a personalized treatment plan designed to support long-term weight management and metabolic health
Nicotinamide riboside chloride: novel food authorisation
The difference is how they get there
In common use, though, people say GLP-1 to mean FDA-approved incretin drugs for weight/diabetes, and peptide therapy to mean other wellness-oriented peptides used off-label for recovery, sleep, and healthy aging
